Drug resistance in cancer chemotherapy as an optimal control problem

Discrete and Continuous Dynamical Systems - Series B

Volumn 6, Issue 1, 2006, Pages 129-150

  Ledzewicz, Urszula ^a   Schättler, Heinz ^b  

^a SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

^b WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

Author keywords

Cancer chemotherapy models; Drug resistance; Optimal control theory

Indexed keywords

EID: 33644522771     PISSN: 15313492     EISSN: None     Source Type: Journal    
DOI: 10.3934/dcdsb.2006.6.129     Document Type: Article

References (33)

1. K. Alitalo, Amplification of cellular oncogenes in cancer cells, Trends Biochem. Sci., 10 (1985), 194-197.
2. P.C. Brown, S.M. Beverly and R.T. Schimke, Relationship of amplified dihydrofolate reductase genes to double minute chromosomes in unstably resistant mouse fibroblast cell lines, Molecular Cell Biology, 1 (1981), 1077-1083.
3. P. Calabresi and P.S. Schein, Medical Oncology, Basic Principles and Clinical Management of Cancer, Mc Graw-Hill, New York, 1993.
4. A.J. Coldman and J.H. Goldie, A model for the resistance of tumor cells to cancer chemotherapeutic agents, Mathematical Biosciences, 65 (1983), 291-307.
5. M.I.S. Costa, J.L. Boldrini and R.C. Bassanezi, Drug kinetics and drug resistance in optimal chemotherapy, Mathematical Biosciences, 125 (1995), 191-209.
6. M. Eisen, Mathematical Models in Cell Biology and Cancer Chemotherapy, Lecture Notes in Biomathematics, Vol. 30, Springer Verlag, (1979).
7. L.E. Harnevo and Z. Agur, The dynamics of gene amplification described as a multitype compartmental model and as a branching process, Mathematical Biosciences, 103 (1991), 115-138.
8. L.E. Harnevo and Z. Agur, Drug resistance as a dynamic process in a model for multistep gene amplification under various levels of selection stringency, Cancer Chemotherapy and Pharmacology, 30 (1992), 469-476.
9. J.H. Goldie, Drug resistance in cancer: a perspective, Cancer and Metastasis Review, 20 (2001), 63-68.
10. R.J. Kaufman, P.C. Brown, and R.T. Schimke, Loss and stabilization of amplified dihydrofolate reductase genes in mouse sarcoma S-180 cell lines, Molecular Cell Biology, 1 (1981), 1084-1093.
11. R.S. Kerbel, A cancer chemotherapy resistant to resistance, Nature, 390 (1997), 335-336.
12. M. Kimmel and D.E. Axelrod, Branching Processes in Biology, Springer Verlag, New York, NY, (2002)
13. M. Kimmel and D.E. Axelrod, Mathematical models of gene amplification with applications to cellular drug resistance and tumorigenicity, Genetics, 125 (1990), 633-644.
14. M. Kimmel, A. Swierniak and A. Polanski, Infinite-dimensional model of evolution of drug resistance of cancer cells, Journal of Mathematical Systems, Estimation and Control, 8 (1998), 1-16.
15. A. Krener, The high-order maximal principle and its application to singular controls, SIAM J. Control and Optimization, 15 (1977), 256-293.
16. L.A. Loeb, A mutator phenotype in cancer, Cancer Research, 61 (2001), 3230-3239
17. U. Ledzewicz and H. Schättler, Optimal bang-bang controls for a 2-compartment model in cancer chemotherapy, Journal of Optimization Theory and Applications - JOTA, 114 (2002), 609-637.
18. U. Ledzewicz and H. Schättler, Analysis of a cell-cycle specific model for cancer chemotherapy, J. of Biological Systems, 10 (2002), 183-206
19. U. Ledzewicz and H. Schättler, On optimal controls for a general mathematical model for chemotherapy of HIV, Proceedings of the 2002 American Control Conference (ACC), Anchorage, Alaska, (2002), 3454-3459.
20. U. Ledzewicz and H. Schättler, Optimal control for a bilinear model with recruiting agent in cancer chemotherapy, Proceedings of the 42nd IEEE Conference on Decision and Control (CDC), Maui, Hawaii, December 2003, 2762-2767.
21. U. Ledzewicz, H. Schättler and A. Swierniak, Finite-dimensional models of drug resistant and phase specific cancer chemotherapy, J. of Medical Informatics and Technologies, 8 (2004), IP 5-13.
22. L.S. Pontryagin, V.G. Boltyanskii, R.V. Gamkrelidze and E.F. Mishchenko, The Mathematical Theory of Optimal Processes, MacMillan, New York, (1964).
23. K. Skomorovski, H. Harpak, A. Iovanovski, M. Vardi, T. Visser, S. Hartong, H. van Vliet, G. Wagemaker and Z. Agur, New TPO treatment schedules of increased safety and efficacy: pre-clinical validation of a thrombopoeisis simulation model, Brit. J. of Haematology, 123 (2003), no. 4, 683ff.
24. R.T. Schimke, Gene amplification, drug resistance and cancer, Cancer Research, 44 (1984), 1735-1742.
25. G.W. Swan, Role of optimal control in cancer chemotherapy, Math. Biosci., 101 (1990), 237-284.
26. J. Smieja and A. Swierniak, Different models of chemotherapy taking into account drug resistance stemming from gene amplification, Int. J. of Appl. Math. Comput. Sci., 13 (2003), 297-305.
27. A. Swierniak, U. Ledzewicz and H. Schättler, Optimal control for a class of compartmental models in cancer chemotherapy, Int. J. of Appl. Math. Comput. Sci., 13 (2003), 357-368
28. A. Swierniak, A. Polanski and M. Kimmel, Optimal control problems arising in cell-cycle-specific cancer chemotherapy, Cell prolif., 29 (1996), 117-139.
29. A. Swierniak, A. Polanski, M. Kimmel, A. Bobrowski and J. Smieja, Qualitative analysis of controlled drug resistance model - inverse Laplace and semigroup approach, Control and Cybernetics, 28 (1999) 61-75.
30. A. Swierniak and J. Smieja, Cancer chemotherapy optimization under evolving drug resistance, Nonlinear Analysis, 47 (2000), 375-386.
31. I.F. Tannock, Tumor physiology and drug resistance, Cancer and Metastasis Reviews, 20 (2001), 123-132.
32. J.J. Westman, B.R. Fabijonas, D.L. Kern and F.B. Hanson, Probabilistic rate compartment cancer model: alternate versus traditional chemotherapy scheduling, in: Stochastic Theory and Control, Proceedings of a Workshop held in Lawrence, Kansas, October 18-20, 2001, Lecture Notes in Control and Information Sciences, B. Pasik-Duncan (Editor), Springer-Verlag, New York, 491-506, (2002).
33. J.J. Westman, B.R. Fabijonas, D.L. Kern and F.B. Hanson, Cancer treatment using multiple chemotherapeutic agents subject to drug resistance, Proc. 15th Int. Symp. of Mathematical Theory of Networks and Systems (MTNS), August 2002.